Concepedia

Gabriela Plesa

GP

Statistics

Publications

56

Citations

13.3K

H-Index

39

Active since

2006

Affiliations

University of Pennsylvania(Current)

Parker Institute for Cancer Immunotherapy

Novartis (United States)

Children's Hospital of Philadelphia

Translational Therapeutics (United States)

Gabriela Plesa is an author at University of Pennsylvania specializing in immunology, immunotherapy, and oncology.

ORCID

Publications per year

2006–2025

56

Publications

56

A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma

Donald M. O’Rourke, MacLean P. Nasrallah, Arati Desai et al. · Science Translational Medicine · 2017 · 1.8K citations · Full text

, , +17

CRISPR-engineered T cells in patients with refractory cancer

Edward A. Stadtmauer, Joseph A. Fraietta, Megan M. Davis et al. · Science · 2020 · 1.4K citations · Full text

, , +17

Gene Editing of <i>CCR5</i> in Autologous CD4 T Cells of Persons Infected with HIV

Pablo Tebas, David Stein, Winson W. Tang et al. · New England Journal of Medicine · 2014 · 1.3K citations · Full text

, , +16

Mesothelin-Specific Chimeric Antigen Receptor mRNA-Engineered T Cells Induce Antitumor Activity in Solid Malignancies

Gregory L. Beatty, Andrew R. Haas, Marcela V. Maus et al. · Cancer Immunology Research · 2013 · 860 citations · Full text

, , +17

B cell maturation antigen–specific CAR T cells are clinically active in multiple myeloma

Adam D. Cohen, Alfred L. Garfall, Edward A. Stadtmauer et al. · Journal of Clinical Investigation · 2019 · 790 citations · Full text

, , +17

1–5 of 56